Harry Veerman

1.5k total citations
14 papers, 1.3k citations indexed

About

Harry Veerman is a scholar working on Cancer Research, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Harry Veerman has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 7 papers in Hematology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Harry Veerman's work include Protease and Inhibitor Mechanisms (12 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Blood properties and coagulation (5 papers). Harry Veerman is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Blood properties and coagulation (5 papers). Harry Veerman collaborates with scholars based in Netherlands, Switzerland and Canada. Harry Veerman's co-authors include Hans Pannekoek, Anton Jan van Zonneveld, Jan A. van Mourik, C. de Vries, P.J. Diergaarde, C L Verweij, Hans Lambers, Titia de Lange, J D Barry and Alberto C.C. Frasch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Harry Veerman

13 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harry Veerman Netherlands	11	847	644	423	309	154	14	1.3k
Jordi Félez Spain	21	875 1.0×	640 1.0×	784 1.9×	171 0.6×	96 0.6×	57	1.7k
F.J. Castellino United States	19	251 0.3×	443 0.7×	488 1.2×	132 0.4×	35 0.2×	42	1.1k
José A. Urı́a Spain	13	715 0.8×	195 0.3×	487 1.2×	69 0.2×	81 0.5×	14	1.2k
Mette Munch Denmark	17	383 0.5×	246 0.4×	340 0.8×	50 0.2×	250 1.6×	24	1.3k
Yoshiro Kamachi Japan	15	310 0.4×	164 0.3×	388 0.9×	59 0.2×	112 0.7×	24	1.1k
Marina Parry United Kingdom	16	199 0.2×	245 0.4×	382 0.9×	87 0.3×	104 0.7×	34	1.0k
Hirofumi Arimura Japan	13	184 0.2×	153 0.2×	309 0.7×	55 0.2×	53 0.3×	26	687
Marja van Meijer Netherlands	13	224 0.3×	290 0.5×	453 1.1×	39 0.1×	39 0.3×	18	919
M R Gyetko United States	7	447 0.5×	271 0.4×	225 0.5×	153 0.5×	91 0.6×	9	834
Alexey M. Chumakov United States	18	203 0.2×	298 0.5×	727 1.7×	47 0.2×	112 0.7×	32	1.3k

Countries citing papers authored by Harry Veerman

Since Specialization

Citations

This map shows the geographic impact of Harry Veerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Veerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Veerman more than expected).

Fields of papers citing papers by Harry Veerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Veerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Veerman. The network helps show where Harry Veerman may publish in the future.

Co-authorship network of co-authors of Harry Veerman

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Veerman. A scholar is included among the top collaborators of Harry Veerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Veerman. Harry Veerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Vries, Carlie de, Harry Veerman, Michael E. Nesheim, & Hans Pannekoek. (1991). Kinetic Characterization of Tissue-Type Plasminogen Activator (t-PA) and t-PA Deletion Mutants. Thrombosis and Haemostasis. 65(3). 280–285. 9 indexed citations

Vries, C. de, et al.. (1990). Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.. Journal of Biological Chemistry. 265(23). 13547–13552. 30 indexed citations

Wagner, Oswald, et al.. (1989). Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.. Journal of Clinical Investigation. 84(2). 647–655. 80 indexed citations

Vries, C. de, Harry Veerman, & Hans Pannekoek. (1989). Identification of the Domains of Tissue-type Plasminogen Activator Involved in the Augmented Binding to Fibrin after Limited Digestion with Plasmin. Journal of Biological Chemistry. 264(21). 12604–12610. 59 indexed citations

Vries, Carlie de, Harry Veerman, Francesco Blasi, & Hans Pannekoek. (1988). Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins. Biochemistry. 27(7). 2565–2572. 39 indexed citations

Loskutoff, David J., M Linders, Jaap Keijer, et al.. (1987). Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns. Biochemistry. 26(13). 3763–3768. 93 indexed citations

Zonneveld, Anton Jan van, Harry Veerman, Just P. J. Brakenhoff, et al.. (1987). Mapping of Epitopes on Human Tissue-Type Plasminogen Activator with Recombinant Deletion Mutant Proteins. Thrombosis and Haemostasis. 57(1). 82–86. 39 indexed citations

Vries, Carlie J.M. de, et al.. (1987). FUNCTIONAL PROPERTIES OF DELETION-MUTANTS OF TISSUE-TYPE PLASMINOGEN ACTIVATOR. Thrombosis and Haemostasis. 1 indexed citations

Pannekoek, Hans, Harry Veerman, Hans Lambers, et al.. (1986). Endothelial plasminogen activator inhibitor: A new member of the serpin gene family. Thrombosis Research. 41. 20–20. 3 indexed citations

10.

Zonneveld, Anton Jan van, Harry Veerman, & Hans Pannekoek. (1986). Autonomous functions of structural domains on human tissue-type plasminogen activator.. Proceedings of the National Academy of Sciences. 83(13). 4670–4674. 195 indexed citations

11.

Pannekoek, Hans, Harry Veerman, Hans Lambers, et al.. (1986). Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.. The EMBO Journal. 5(10). 2539–2544. 293 indexed citations

12.

Zonneveld, Anton Jan van, Harry Veerman, Marcy E. MacDonald, Hans Pannekoek, & Jan A. van Mourik. (1986). Structure and function of human tissue‐type plasminogen activator (t‐PA). Journal of Cellular Biochemistry. 32(3). 169–178. 75 indexed citations

13.

Zonneveld, Anton Jan van, Harry Veerman, & Hans Pannekoek. (1986). On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.. Journal of Biological Chemistry. 261(30). 14214–14218. 202 indexed citations

14.

Lange, Titia de, et al.. (1984). Comparison of the genes coding for the common 5′ terminal sequence of messenger RNAs in three trypanosome species. Nucleic Acids Research. 12(11). 4431–4443. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact